| P50 | author | Afranio L Kritski | Q56399355 |
| | Milton Wainberg | Q77291366 |
| P2093 | author name string | M A Oquendo | |
| | E C Silva | |
| | M O Moraes | |
| | M E Sublette | |
| | A Norcini Pala | |
| | A Karpati | |
| | A C Sweetland | |
| | J R Lapa E Silva | |
| | L R Batista Silva | |
| P2860 | cites work | Depression: a silent driver of the global tuberculosis epidemic | Q41787284 |
| | Tuberculosis and nutrition | Q42270487 |
| | Selective serotonin reuptake inhibitors and isoniazid: evidence of a potential adverse interaction | Q43428125 |
| | IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity | Q45115322 |
| | Association between cancer stigma and depression among cancer survivors: a nationwide survey in Korea. | Q46032225 |
| | Multidrug-resistant tuberculosis treatment programmes insufficiently consider comorbid mental disorders. | Q47729018 |
| | Depression and risk of tuberculosis: a nationwide population-based cohort study | Q47850385 |
| | WHO's new end TB strategy. | Q50995464 |
| | Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease. | Q52174134 |
| | Stigma as a fundamental cause of population health inequalities. | Q52639129 |
| | Detection of interleukin-2 in addition to interferon-γ discriminates active tuberculosis patients, latently infected individuals, and controls | Q57632331 |
| | [Social representations of tuberculosis: stigma and prejudice] | Q79982844 |
| | Altered cortisol/DHEA ratio in tuberculosis patients and its relationship with abnormalities in the mycobacterial-driven cytokine production by peripheral blood mononuclear cells | Q80517117 |
| | Psychosocial support groups for patients with multidrug-resistant tuberculosis: five years of experience | Q83470800 |
| | So depression is an inflammatory disease, but where does the inflammation come from? | Q21245291 |
| | Nutritional therapies for mental disorders | Q21245899 |
| | From inflammation to sickness and depression: when the immune system subjugates the brain | Q24633527 |
| | Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review | Q26774846 |
| | Mental health collaborative care and its role in primary care settings | Q26999874 |
| | Tuberculosis Treatment Non-Adherence and Lost to Follow Up among TB Patients with or without HIV in Developing Countries: A Systematic Review | Q28087010 |
| | Understanding nutrition, depression and mental illnesses | Q28258040 |
| | Engagement of the Aryl Hydrocarbon Receptor in Mycobacterium tuberculosis-Infected Macrophages Has Pleiotropic Effects on Innate Immune Signaling | Q28267904 |
| | Patient adherence to tuberculosis treatment: a systematic review of qualitative research | Q28469261 |
| | The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis | Q28475461 |
| | Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior | Q28508390 |
| | Psychological and Educational Intervention to Improve Tuberculosis Treatment Adherence in Ethiopia Based on Health Belief Model: A Cluster Randomized Control Trial | Q28551963 |
| | Syndemics and Public Health: Reconceptualizing Disease in Bio-Social Context | Q29010791 |
| | A meta-analysis of cytokines in major depression | Q29617325 |
| | Grand challenges: integrating mental health services into priority health care platforms | Q30393715 |
| | The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review | Q30955276 |
| | A systematic review of delay in the diagnosis and treatment of tuberculosis | Q33314674 |
| | Alcohol use as a risk factor for tuberculosis - a systematic review | Q33360105 |
| | Factors associated with deaths among pulmonary tuberculosis patients: a case-control study with secondary data. | Q33391306 |
| | Stigma, social support, and depression among people living with HIV in Thailand | Q33579821 |
| | Common mental disorders in TB/HIV co-infected patients in Ethiopia | Q33629420 |
| | Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review | Q33692632 |
| | CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression | Q33751166 |
| | Tuberculosis and stigmatization: pathways and interventions | Q33902962 |
| | Measuring depression and anxiety in sub-saharan Africa | Q33944821 |
| | Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence | Q33974684 |
| | Clinical and physiological consequences of rapid tryptophan depletion | Q34076826 |
| | Cytokine targets in the brain: impact on neurotransmitters and neurocircuits | Q34078917 |
| | Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression | Q34124031 |
| | Inflammation-associated depression: from serotonin to kynurenine | Q34147377 |
| | M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection | Q34287451 |
| | Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis. | Q34316105 |
| | Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry | Q34333096 |
| | ??? | Q26853444 |
| | Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. | Q34655648 |
| | Depression and immune function: central pathways to morbidity and mortality | Q34959869 |
| | Clinical and health services relationships between major depression, depressive symptoms, and general medical illness | Q35189628 |
| | Epidemiology and treatment of depression in patients with chronic medical illness. | Q35237231 |
| | Psychiatric issues in the management of patients with multidrug-resistant tuberculosis. | Q35795064 |
| | Serum indoleamine 2,3-dioxygenase activity predicts prognosis of pulmonary tuberculosis | Q35805226 |
| | Depression among patients with tuberculosis: determinants, course and impact on pathways to care and treatment outcomes in a primary care setting in southern Ethiopia--a study protocol | Q35844195 |
| | Collaborative care for patients with depression and chronic illnesses | Q35854207 |
| | Stress, depression, the immune system, and cancer | Q35909595 |
| | Glucocorticoids, cytokines and brain abnormalities in depression | Q36442019 |
| | The association of depression and anxiety with medical symptom burden in patients with chronic medical illness | Q36750861 |
| | Psychiatric morbidity and other factors affecting treatment adherence in pulmonary tuberculosis patients | Q36830922 |
| | Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment | Q36959143 |
| | Medical co-morbidity in depressive disorders. | Q37023965 |
| | Major depression and comorbid substance use disorders. | Q37087213 |
| | Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications | Q37089253 |
| | Tuberculosis control in vulnerable groups | Q37113116 |
| | A prospective evaluation of the directionality of the depression-inflammation relationship | Q37359708 |
| | Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? | Q37392195 |
| | A consistent log-linear relationship between tuberculosis incidence and body mass index | Q37612651 |
| | Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans | Q37619648 |
| | Pleural fluid from tuberculous pleurisy inhibits the functions of T cells and the differentiation of Th1 cells via immunosuppressive factors | Q37729535 |
| | Poverty and mental disorders: breaking the cycle in low-income and middle-income countries | Q37947008 |
| | Collaborative care to improve the management of depressive disorders: a community guide systematic review and meta-analysis | Q38003793 |
| | A review of the interplay between tuberculosis and mental health | Q38105452 |
| | Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis. | Q38111880 |
| | A systematic review of global cultural variations in knowledge, attitudes and health responses to tuberculosis stigma | Q38178806 |
| | Serotonin modulation of macrophage polarization: inflammation and beyond | Q38231265 |
| | Factors associated with mortality in tuberculosis patients | Q38867253 |
| | Phenothiazines, bacterial efflux pumps and targeting the macrophage for enhanced killing of intracellular XDRTB. | Q38872102 |
| | Factors associated with drug resistance in pulmonary tuberculosis. | Q39395624 |
| | Interferon-alpha therapy in patients with hepatitis C virus infection increases plasma phenylalanine and the phenylalanine to tyrosine ratio | Q39672986 |
| | Protein-calorie malnutrition, macronutrient supplements, and tuberculosis | Q39692345 |
| | Psychotherapy improves compliance with tuberculosis treatment | Q39726257 |
| | The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression | Q40385577 |
| | The host immune response to tuberculosis | Q41727902 |
| P433 | issue | 8 | |
| P921 | main subject | tuberculosis | Q12204 |
| P304 | page(s) | 852-861 | |
| P577 | publication date | 2017-08-01 | |
| P1433 | published in | International Journal of Tuberculosis and Lung Disease | Q15767020 |
| P1476 | title | Addressing the tuberculosis-depression syndemic to end the tuberculosis epidemic | |
| P478 | volume | 21 | |